- Home
- DIBS vs PLRX Comparison
DIBS vs PLRX Comparison
Compare DIBS & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIBS
- PLRX
- Stock Information
- Founded
- DIBS 2000
- PLRX 2015
- Country
- DIBS United States
- PLRX United States
- Employees
- DIBS 284
- PLRX N/A
- Industry
- DIBS Catalog/Specialty Distribution
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- DIBS Consumer Discretionary
- PLRX Health Care
- Exchange
- DIBS Nasdaq
- PLRX Nasdaq
- Market Cap
- DIBS 86.4M
- PLRX 87.0M
- IPO Year
- DIBS 2021
- PLRX 2020
- Fundamental
- Price
- DIBS $2.45
- PLRX $1.46
- Analyst Decision
- DIBS Hold
- PLRX Hold
- Analyst Count
- DIBS 1
- PLRX 10
- Target Price
- DIBS N/A
- PLRX $9.79
- AVG Volume (30 Days)
- DIBS 123.8K
- PLRX 1.4M
- Earning Date
- DIBS 05-09-2025
- PLRX 05-05-2025
- Dividend Yield
- DIBS N/A
- PLRX N/A
- EPS Growth
- DIBS N/A
- PLRX N/A
- EPS
- DIBS N/A
- PLRX N/A
- Revenue
- DIBS $88,257,000.00
- PLRX N/A
- Revenue This Year
- DIBS $5.47
- PLRX N/A
- Revenue Next Year
- DIBS $6.46
- PLRX N/A
- P/E Ratio
- DIBS N/A
- PLRX N/A
- Revenue Growth
- DIBS 4.22
- PLRX N/A
- 52 Week Low
- DIBS $2.30
- PLRX $1.10
- 52 Week High
- DIBS $6.20
- PLRX $16.52
- Technical
- Relative Strength Index (RSI)
- DIBS 31.53
- PLRX 37.18
- Support Level
- DIBS $2.33
- PLRX $1.10
- Resistance Level
- DIBS $2.49
- PLRX $1.34
- Average True Range (ATR)
- DIBS 0.20
- PLRX 0.12
- MACD
- DIBS -0.00
- PLRX 0.15
- Stochastic Oscillator
- DIBS 17.34
- PLRX 88.45
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The Company has a single reportable and operating segment that contains one reporting unit, which consists of the Company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.